Stroke, a leading cause of morbidity and mortality worldwide, often presents as a medical emergency. Early recognition and prompt management are critical to improve patient outcomes. This article outlines key strategies for early stroke recognition and management.
Stroke symptoms often appear suddenly and vary depending on the affected brain area. The FAST (Face drooping, Arm weakness, Speech difficulties, and Time to call emergency services) acronym is a widely recognized tool for identifying potential stroke. However, clinicians should also consider other signs such as sudden vision changes, dizziness, and severe headache.
Upon suspecting a stroke, immediate diagnostic measures should be initiated. Neuroimaging, particularly non-contrast computed tomography (CT), is the initial diagnostic modality of choice. It helps identify the stroke type, guiding further management. Other investigations like blood tests and electrocardiogram may be necessary to rule out stroke mimics and identify potential etiologies.
Once a stroke is confirmed, prompt initiation of treatment is crucial. For ischemic strokes, intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) is the standard of care if administered within 4.5 hours of symptom onset. In select cases, endovascular thrombectomy may be considered. For hemorrhagic strokes, management is primarily supportive, focusing on blood pressure control and neurosurgical interventions when necessary.
Stroke care is multidisciplinary, involving neurologists, radiologists, nurses, and rehabilitation therapists. Coordinated care through a stroke team or stroke unit can significantly improve patient outcomes.
Early recognition and management of stroke are pivotal to minimize neurological damage and improve patient outcomes. Clinicians should familiarize themselves with the signs of stroke, employ appropriate diagnostic strategies, and initiate prompt treatment. Multidisciplinary care is integral to effective stroke management.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation